China's Jiangsu Zenji (Zhengji) Pharmaceutical to Increase 2020 Capex, an Industrial Info Market Brief
China's Jiangsu Zenji (Zhengji) Pharmaceutical to Increase 2020 Capex, an Industrial Info Market Brief
Attachment: 2
Jiangsu Zenji (Zhengji) Pharmaceutical will ratchet up its capital expenditures next year to $155 million, executives with the specialty producer said recently. Permitting was finalized during the fourth quarter for the company's planned active pharmaceutical ingredients (Levocarnitine Oral Solution, DL-Thioctic acid) grassroot plant in Shandong, China.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- France Plans $55 Billion in Windfarms as Offshore Projects Gain Momentum
- Africa's Fertilizer Demand Sparks $5.8 Billion of Projects
- Poland's PGE Plans $7 Billion Renewable Energy Push
- Peru's Runoff Presidential Election Could Impact $45 Billion in Mining Proj...
- Industrial Construction Activity Up 37% So Far in 2021